Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke.

Thumbnail
Name:
journal.pone.0189339.pdf
Size:
2.842Mb
Format:
PDF
Description:
Main Article
Download
Authors
Rohde, Daniela
Merriman, Niamh A
Doyle, Frank
Bennett, Kathleen
Williams, David
Hickey, Anne
Issue Date
2017-12-08
Keywords
COGNITIVE IMPAIRMENT
MEDICATION MANAGEMENT
Local subject classification
STROKE

Metadata
Show full item record
Citation
Does cognitive impairment impact adherence? A systematic review and meta-analysis of the association between cognitive impairment and medication non-adherence in stroke. 2017, 12 (12):e0189339 PLoS ONE
Publisher
PLoS ONE
Journal
PloS one
URI
http://hdl.handle.net/10147/622697
DOI
10.1371/journal.pone.0189339
PubMed ID
29220386
Additional Links
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189339
Abstract
Few studies have explored associations between cognitive impairment and medication adherence post-stroke, with substantial heterogeneity in study populations, and definitions and assessments of non-adherence and cognitive impairment. Further research using clear, standardised and objective assessments is needed to clarify the association between cognitive impairment and medication non-adherence in stroke.
Item Type
Article
Language
en
Description
While medication adherence is essential for the secondary prevention of stroke, it is often sub-optimal, and can be compromised by cognitive impairment. This study aimed to systematically review and meta-analyse the association between cognitive impairment and medication non-adherence in stroke.
ISSN
1932-6203
Collections